Yiling Xu

1.3k total citations
18 papers, 1.1k citations indexed

About

Yiling Xu is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Yiling Xu has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Yiling Xu's work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (6 papers) and T-cell and B-cell Immunology (5 papers). Yiling Xu is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (6 papers) and T-cell and B-cell Immunology (5 papers). Yiling Xu collaborates with scholars based in United States, China and France. Yiling Xu's co-authors include David R. Nelson, Chen Liu, Roniel Cabrera, Roberto J. Firpi, Zhengkun Tu, Hugo R. Rosen, Mengde Cao, Miguel Ararat, Mark A. Atkinson and Clive Wasserfall and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Hepatology.

In The Last Decade

Yiling Xu

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiling Xu United States 11 574 367 275 274 146 18 1.1k
Fariba Barahmand-Pour United States 10 531 0.9× 134 0.4× 170 0.6× 338 1.2× 213 1.5× 10 890
Takayuki Yakushijin Japan 19 352 0.6× 624 1.7× 467 1.7× 181 0.7× 217 1.5× 64 1.1k
Zhongming Tan China 12 344 0.6× 250 0.7× 312 1.1× 177 0.6× 271 1.9× 24 914
Steffen Zopf Germany 17 335 0.6× 220 0.6× 235 0.9× 193 0.7× 305 2.1× 45 1.0k
Ana I. Romero Sweden 15 423 0.7× 517 1.4× 421 1.5× 166 0.6× 213 1.5× 25 1.1k
Junko Yokokawa Japan 18 634 1.1× 252 0.7× 286 1.0× 546 2.0× 271 1.9× 30 1.2k
A. Castellaneta Italy 18 627 1.1× 180 0.5× 151 0.5× 117 0.4× 139 1.0× 36 1.0k
Mathis Heydtmann United Kingdom 12 226 0.4× 672 1.8× 559 2.0× 141 0.5× 69 0.5× 31 1.1k
Hiroyuki Shimomura Japan 17 132 0.2× 500 1.4× 493 1.8× 98 0.4× 241 1.7× 58 1.1k
Vanessa Teaberry United States 8 190 0.3× 273 0.7× 486 1.8× 83 0.3× 317 2.2× 8 893

Countries citing papers authored by Yiling Xu

Since Specialization
Citations

This map shows the geographic impact of Yiling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiling Xu more than expected).

Fields of papers citing papers by Yiling Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiling Xu. The network helps show where Yiling Xu may publish in the future.

Co-authorship network of co-authors of Yiling Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiling Xu. A scholar is included among the top collaborators of Yiling Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiling Xu. Yiling Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ghayee, Hans K., Yiling Xu, Heather Hatch, et al.. (2024). Polyamine Pathway Inhibitor DENSPM Suppresses Lipid Metabolism in Pheochromocytoma Cell Line. International Journal of Molecular Sciences. 25(18). 10029–10029.
3.
Ghayee, Hans K., Yiling Xu, Heather Hatch, et al.. (2022). Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis. International Journal of Molecular Sciences. 24(1). 584–584. 1 indexed citations
4.
Nelson, David R., et al.. (2014). Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MSMS. Liver International. 34(9). 1428–1444. 98 indexed citations
5.
Korelitz, James, et al.. (2012). Prevalence of Thyrotoxicosis, Antithyroid Medication Use, and Complications Among Pregnant Women in the United States. Thyroid. 23(6). 758–765. 69 indexed citations
6.
Cabrera, Roniel, Miguel Ararat, Yiling Xu, et al.. (2012). Serum levels of soluble CD25 as a marker for hepatocellular carcinoma. Oncology Letters. 4(4). 840–846. 12 indexed citations
7.
Cabrera, Roniel, Miguel Ararat, Yiling Xu, et al.. (2012). Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma. Cancer Immunology Immunotherapy. 62(4). 737–746. 91 indexed citations
8.
Cao, Mengde, Yiling Xu, Je‐In Youn, et al.. (2011). Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model. Laboratory Investigation. 91(4). 598–608. 106 indexed citations
9.
Eksioglu, Erika A., Graham L. Jones, Hui‐Jia Dong, et al.. (2010). Characterization of Anti-HCV Antibodies in IL-10-Treated Patients. Viral Immunology. 23(4). 359–368. 3 indexed citations
10.
Cao, Mengde, Roniel Cabrera, Yiling Xu, Chen Liu, & David R. Nelson. (2010). Different radiosensitivity of CD4+CD25+regulatory T cells and effector T cells to low dose gamma irradiation in vitro. International Journal of Radiation Biology. 87(1). 71–80. 42 indexed citations
11.
Cao, Mengde, Roniel Cabrera, Yiling Xu, Chen Liu, & David R. Nelson. (2009). Gamma irradiation alters the phenotype and function of CD4 + CD25 + regulatory T cells. Cell Biology International. 33(5). 565–571. 51 indexed citations
12.
Cabrera, Roniel, Miguel Ararat, Mengde Cao, et al.. (2009). Hepatocellular Carcinoma Immunopathogenesis: Clinical Evidence for Global T Cell Defects and an Immunomodulatory Role for Soluble CD25 (sCD25). Digestive Diseases and Sciences. 55(2). 484–495. 31 indexed citations
13.
Korelitz, James, Julie M. Zito, Norma I. Gavin, et al.. (2008). Asthma-related medication use among children in the United States. Annals of Allergy Asthma & Immunology. 100(3). 222–229. 10 indexed citations
14.
Cao, Mengde, Yiling Xu, Roniel Cabrera, Chen Liu, & David R. Nelson. (2007). Gamma irradiation alters the phenotype and function of CD4+CD25+ regulatory T cells (88.2). The Journal of Immunology. 178(1_Supplement). S138–S138. 4 indexed citations
15.
Cao, Mengde, Roniel Cabrera, Yiling Xu, et al.. (2007). Hepatocellular carcinoma cell supernatants increase expansion and function of CD4+CD25+ regulatory T cells. Laboratory Investigation. 87(6). 582–590. 64 indexed citations
16.
Liu, Chen, Haizhen Zhu, G. Mani Subramanian, et al.. (2007). Anti‐hepatitis C virus activity of albinterferon alfa‐2b in cell culture. Hepatology Research. 37(11). 941–947. 20 indexed citations
17.
Cabrera, Roniel, Zhengkun Tu, Yiling Xu, et al.. (2004). An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection. Hepatology. 40(5). 1062–1071. 448 indexed citations
18.
Tu, Zhengkun, et al.. (2003). An immunomodulatory role for CD4+ CD25+ T lymphocytes in hepatitis C infection. Gastroenterology. 124(4). A710–A710. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026